Table 3.
The association between urinary phthalate metabolites and the prevalence of cardiovascular disease among CKD patients with different renal functions.
| Phthalates | >90 mL/min/1.73m2 (n = 221) | 60–90 mL/min/1.73m2 (n = 156) | <60 mL/min/1.73m2 (n = 457) | P for interaction |
|---|---|---|---|---|
| MEP | 0.99 (0.62, 1.59) | 0.93 (0.72, 1.20) | 1.08 (0.89, 1.32) | 0.850 |
| MEHHP | 0.91 (0.41, 2.05) | 1.68 (0.88, 3.20) | 1.13 (0.88, 1.46) | 0.852 |
| MiBP | 1.03 (0.34, 3.15) | 1.96 (1.15, 3.35) | 1.20 (0.89, 1.62) | 0.907 |
| MEOHP | 0.93 (0.39, 2.21) | 2.50 (1.29, 4.84) | 1.11 (0.86, 1.45) | 0.477 |
| MBzP | 1.19 (0.65, 2.16) | 1.16 (0.72, 1.88) | 1.12 (0.86, 1.46) | 0.577 |
| MCNP | 1.85 (0.98, 3.51) | 1.23 (0.77, 1.96) | 1.19 (0.89, 1.58) | 0.186 |
| MCOP | 1.46 (0.80, 2.65) | 1.63 (1.00, 2.67) | 1.00 (0.82, 1.23) | 0.076 |
| MECPP | 1.44 (0.63, 3.31) | 3.31 (1.62, 6.79) | 1.12 (0.85, 1.46) | 0.029 |
| MBP | 0.71 (0.27, 1.85) | 0.99 (0.43, 2.26) | 1.59 (1.12, 2.25) | 0.036 |
| MCPP | 1.00 (0.60, 1.66) | 1.29 (0.73, 2.28) | 1.05 (0.87, 1.26) | 0.995 |
The models were adjusted for age, gender, race/ethnicity, PIR, BMI, smoking status, hypertension, diabetes, total cholesterol, and eGFR.